Trim SPCX 40–50% into $138–$141.73 resistance; cap residual at 50% of prior position and 2% portfolio NAV
Underweight SPCX to reflect near-term distribution (below 10 EMA and 50/200 SMA resistance at $141.73), unresolved lockup supply absorption (117M shares), premium valuation (~76x sales, ~80x forward earnings), negative trailing cash flow ($14.1B TTM FCF), and binary Starship execution risk. The strategic foundation (66% sequential revenue growth, EBITDA turnaround from -$1.16B to +$2.96B, ~$93.5B cash) prevents a full exit but does not justify full exposure without confirmation. Execute 40–50% trim into rallies; liquidate remainder on weekly close below $108.
| Position | Action |
|---|---|
| Reduce 40–50% of existing SPCX shares | SELL 40–50% of position into rallies at $138–$141.73 |
| Residual position cap | Keep no more than 50% of prior allocation, capped at 2% of portfolio NAV |
| New positions | Do not initiate new long positions |
| Do not add at $134 | Avoid adding at current levels |
SPCX at $134 is a generational entry point, not a HOLD—the most aggressive fundamental inflection in the commercial space sector is unfolding with Q2 2026 revenue up 66.4% Q/Q, EBITDA swinging $4.1B positive, and a $93.5B cash war chest funding years of capex, making the technical consolidation a coiled launchpad rather than a bearish transition.
| Indicator | Value | Signal |
|---|---|---|
| Close | 134.00 | bearish |
| Open | 137.29 | neutral |
| High | 137.88 | neutral |
| Low | 130.39 | neutral |
| Volume | 117,409,257 | neutral |
| 10 EMA | 136.55 | bearish |
| 50 SMA | 141.73 | bearish |
| 200 SMA | 141.73 | neutral |
| RSI | 49.89 | neutral |
| MACD | +2.19 | bearish |
| MACD Signal | -0.14 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Current price around $134
Then: Do not add position
The balance sheet is a fortress with $93.5B in cash providing multi-year capex runway
↩ rebuts: “Bear's dilution risk concern is misplaced; 0.7% share increase is not meaningful dilution”
EV: +15.4% (upper Bollinger at $154.63) · concedes: ATR at 10.12 means position sizing matters; Stock needs to clear 141.73 on volume to confirm technical reversal; Add on test of 20 SMA at $126.85; Stop on weekly close below $108; The bear's lockup unlock 'caps upside for 1-4 weeks' has known, finite duration
SpaceX's single-quarter EBITDA inflection is insufficient to justify a $1.77T valuation given $14B annual FCF burn, extreme speculative multiples, confirmed technical downtrend, and a stacking bearish catalyst calendar that risks a negative cascade.
· concedes: Q2 revenue jump of $7.81B is a real number; Gross margins at 52% with positive trajectory; Starship progress is genuine even if delayed; SpaceX has real moats across seven capabilities; Defense and Starlink revenue is real
→ vs conservative: Overweighting short-term price action and underweighting fundamental inflection; pattern-matching to a chart while ignoring 66% revenue jump and positive EBITDA print; ignoring the macro catalyst path including dovish Fed surprise and Anthropic IPO re-rating
→ vs conservative: Treating the 85.7 billion equity raise and lockup unlock as permanent liability rather than one-time fully digested event; fortress balance sheet thesis is contradicted by selling a company with 93 billion in cash and maximum growth optionality
→ vs neutral: Waiting for confirmation to reclaim 141.73 means missing 6% upside already; perfection doesn't exist in high-growth compounders; waiting for Starship confirmation means missing the gap on announcement day (historically 15%)
→ vs neutral: Neutral stance is a polite way of saying no edge and guarantees capturing none of the rerating while accepting all downside risk
→ vs aggressive: The trader's SELL decision is a hedge dressed as discipline; 141.73 resistance is a waypoint, not a ceiling; trimming into strength means selling into a rally that extends another 30%
| MACD Histogram | +2.33 | bearish |
| Bollinger Upper | 154.63 | bearish |
| Bollinger Middle | 126.85 | neutral |
| Bollinger Lower | 99.06 | bullish |
| ATR | 10.12 | bearish |
| VWMA | 129.29 | bearish |
Support: 126.85 · 129.29 · 108.37 · 99.06 | Resistance: 136.55 · 141.73 · 154.63 · 149.8
SPCX is in a confirmed bearish downtrend from its ~$211 peak (2026-06-16) to its ~$108 trough (2026-07-31), representing a ~49% decline. The subsequent bounce rally to $149.80 (2026-08-17) appears to be failing, with the last three sessions printing lower highs and lower closes (146.23 → 143.34 → 139.65 → 134.00). The MACD histogram has declined for three straight sessions (4.22 → 3.88 → 3.24 → 2.33), signaling bearish momentum divergence. RSI at 49.89 indicates the stock is not oversold, leaving downside risk unexhausted. Key levels to watch: resistance at 141.73 (50/200 SMA) and 136.55 (10 EMA); support at 126.85 (20 SMA/Boll Mid), 108.37 (recent low), and 99.06 (lower Bollinger). Final recommendation: HOLD — the path of least resistance is lower toward 126.85/108, but a clean breakdown below 130.39 has not yet confirmed, warranting patience before committing fresh capital.
Market Cap
$1,766.36B
Forward P/E
80.77
Price-to-Book
13.88
EPS (TTM)
-$1.10
Forward EPS
$1.66
Book Value per Share
$9.66
TTM Revenue
$23.04B
TTM Gross Profit
$11.95B
Gross Margin (TTM)
51.9%
TTM EBITDA
$5.90B
TTM Net Income
-$8.89B
Operating Margin (TTM)
-1.8%
Profit Margin (TTM)
-35.7%
Revenue Growth (FY25 vs FY24)
+33.2%
Q2 2026 Revenue Q/Q
+66.4%
Gross Margin Expansion (2023→TTM)
+10.7 pp
Current Ratio
5.12
Cash (Jun 2026)
$93.52B
Total Debt (Jun 2026)
$39.71B
Debt-to-Equity
31.2%
FY2025 Operating CF
$6.79B
FY2025 CapEx
-$20.74B
FY2025 Free Cash Flow
-$14.12B
Q2 2026 Stock Issuance
$85.68B
Total Assets (Jun 2026)
$192.77B
Stockholders' Equity (Jun 2026)
$127.22B
Net PP&E (Jun 2026)
$66.85B
Shares Outstanding (Jun 2026)
13.18B
52-Week High
$225.64
52-Week Low
$104.83
50/200-Day MA
$141.89
FY2023 Revenue
$10.39B
FY2024 Revenue
$14.02B
FY2025 Revenue
$18.67B
Q1 2026 Revenue
$4.69B
Q2 2026 Revenue
$7.81B
FY2025 R&D Expense
$8.64B
FY2025 Gross Margin
49.4%
FY2023 Gross Margin
41.2%
Q2 2026 EBITDA
$2.96B
Q1 2026 EBITDA
-$1.16B
Working Capital (Jun 2026)
$86.93B
Goodwill & Intangibles
$14.04B
Construction in Progress
$12.55B
Q2 2026 CapEx
$18.37B
Annualized 2026 R&D
~$14B
Depreciation FY2025
$5.92B
Depreciation Q2 2026
$2.74B
Annual Interest Expense
$1.3B+
Strengths
Concerns
SPCX is a high-growth aerospace and defense company with a Q2 2026 inflection showing revenue acceleration (+66.4% Q/Q to $7.81B), EBITDA turning positive ($2.96B), and gross margins expanding to 52%. The massive $85.7B equity raise transformed the balance sheet with $93.52B in cash, but free cash flow remains deeply negative (-$14.12B FY2025) due to aggressive CapEx ($20.74B) and R&D ($8.64B) investments in Starship and Starlink V3. The stock is richly valued (Forward P/E 80.77, P/B 13.88) but underpinned by accelerating fundamentals, warranting a HOLD recommendation with positive bias given the improving profitability trajectory.
Macro: Risk-off environment: Trump's 'economic warfare' rhetoric against Iran lifted oil and yields. Polymarket prices no Fed cuts in 2026 at 86% (+0.1pp wk) — higher-for-longer is a structural headwind for high-duration growth equities. Strait of Hormuz disruption risk at 70% (+15pp wk). US recession-by-end-2026 priced at just 8%. Renewed bond selloff (US bond selloff resumes despite Treasury intervention per AFP; Wall Street sinks as bond yields rise per Reuters). Castelion hit $13B valuation for hypersonic missile production — bullish for defense/space complex.